Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay

Clinical and Vaccine Immunology

Volumn 17, Issue 1, 2010, Pages 194-198

  Ko, Young Joon ^a,d   Lee, Hyang Sim ^a   Jeoung, Hye Young ^a   Heo, Eun Jeong ^a   Ko, Hyo Rim ^a   Chang, Byung Sik ^b   Joo, Hoo Don ^b   Gerelmaa, U ^c   Dashzeveg, B ^c   Tserendorj, S ^c   Sodnomdarjaa, R ^c   Park, Jong Hyeon ^a   Kweon, Chang Hee ^a   Cho, In Soo ^a   Paik, Sang Gi ^d  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Jenobiotech Inc   (South Korea)

^c State Central Veterinary Laboratory   (Mongolia)

^d Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

STRUCTURAL PROTEIN;

ANTIBODY DETECTION; ARTICLE; ASSAY; BACULOVIRUS EXPRESSION SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE VIRUS; INHIBITION KINETICS; LIQUID PHASE MICROEXTRACTION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BACULOVIRIDAE; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; GOATS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 74549168517     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00374-09     Document Type: Article

References (27)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716.
2. Barnett, P. V., R. J. Statham, W. Vosloo, and D. T. Haydon. 2003. Foot-andmouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21:3240-3248.
3. Belsham, G. J. 1993. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol. 60:241-260.
4. Bittle, J. L., R. A. Houghten, H. Alexander, T. M. Shinnick, J. G. Sutcliffe, R. A. Lerner, D. J. Rowlands, and F. Brown. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30-33.
5. Cao, Y., Z. Lu, J. Sun, X. Bai, P. Sun, H. Bao, Y. Chen, J. Guo, D. Li, X. Liu, and Z. Liu. 2009. Synthesis of empty capsid-like particles of Asia I foot-andmouth disease virus in insect cells and their immunogenicity in guinea pigs. Vet. Microbiol. 137:10-17.
6. Chenard, G., K. Miedema, P. Moonen, R. S. Schrijver, and A. Dekker. 2003. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J. Virol. Methods 107: 89-98.
7. Chung, Y. C., J. H. Huang, C. W. Lai, H. C. Sheng, S. R. Shih, M. S. Ho, and Y. C. Hu. 2006. Expression, purification and characterization of enterovirus-71 virus-like particles. World J. Gastroenterol. 12:921-927.
8. Cooke, J. N., and K. M. Westover. 2008. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis. Infect. Genet. Evol. 8:855-863.
9. Goris, N., E. Maradei, R. D'Aloia, N. Fondevila, N. Mattion, A. Perez, E. Smitsaart, H. J. Nauwynck, J. La Torre, E. Palma, and K. De Clercq. 2008. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test. Vaccine 26:3432-3437.
10. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
11. Hamblin, C., I. T. Barnett, and R. S. Hedger. 1986. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against footand-mouth disease virus. I. Development and method of ELISA. J. Immunol. Methods 93:115-121.
12. Kitching, P., J. Hammond, M. Jeggo, B. Charleston, D. Paton, L. Rodriguez, and R. Heckert. 2007. Global FMD control - is it an option? Vaccine 25: 5660-5664.
13. Klein, J. 2009. Understanding the molecular epidemiology of foot-andmouth-disease virus. Infect. Genet. Evol. 9:153-161.
14. Knowles, N. J., M. H. Nazem Shirazi, J. Wadsworth, K. G. Swabey, J. M. Stirling, R. J. Statham, Y. Li, G. H. Hutchings, N. P. Ferris, U. Parlak, F. Ozyoruk, K. J. Sumption, D. P. King, and D. J. Paton. 2009. Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle East. Transbound. Emerg. Dis. 56:157-169.
15. Knowles, N. J., and A. R. Samuel. 2003. Molecular epidemiology of footand-mouth disease virus. Virus Res. 91:65-80.
16. Ko, Y. J., H. Y. Jeoung, H. S. Lee, B. S. Chang, S. M. Hong, E. J. Heo, K. N. Lee, H. D. Joo, S. M. Kim, J. H. Park, and C. H. Kweon. 2009. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1. J. Virol. Methods 159:112-118.
17. Li, Z., Y. Yi, X. Yin, Z. Zhang, and J. Liu. 2008. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS One 3:e2273.
18. Mackay, D. K., A. N. Bulut, T. Rendle, F. Davidson, and N. P. Ferris. 2001. A solid-phase competition ELISA for measuring antibody to foot-andmouth disease virus. J. Virol. Methods 97:33-48.
19. Niedbalski, W. 2004. Comparison of different ELISA methods for the detection of antibodies against foot-and-mouth disease virus (FMDV) type O. Bull. Vet. Inst. Pulawy 48:5-9.
20. Oem, J. K., J. H. Park, K. N. Lee, Y. J. Kim, S. J. Kye, J. Y. Park, and H. J. Song. 2007. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine 25:4112-4121.
21. OIE. 2008. Foot-and-mouth disease, p. 198-199. In OIE manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees). OIE, Paris, France.
22. Pfaff, E., M. Mussgay, H. O. Bohm, G. E. Schulz, and H. Schaller. 1982. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1:869-874.
23. Robiolo, B., P. R. Grigera, O. H. Periolo, C. Seki, T. Bianchi, E. Maradei, and J. L. La Torre. 1995. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13:1346-1352.
24. Strohmaier, K., R. Franze, and K. H. Adam. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59:295-306.
25. Sugiyama, M., R. Yoshiki, Y. Tatsuno, S. Hiraga, O. Itoh, K. Gamoh, and N. Minamoto. 1997. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs. Clin. Diagn. Lab. Immunol. 4:727-730.
26. Valarcher, J. F., N. J. Knowles, V. Zakharov, A. Scherbakov, Z. Zhang, Y. J. Shang, Z. X. Liu, X. T. Liu, A. Sanyal, D. Hemadri, C. Tosh, T. J. Rasool, B. Pattnaik, K. R. Schumann, T. R. Beckham, W. Linchongsubongkoch, N. P. Ferris, P. L. Roeder, and D. J. Paton. 2009. Multiple origins of foot-and-mouth disease virus serotype Asia 1 outbreaks, 2003-2007. Emerg. Infect. Dis. 15:1046-1051.
27. Valarcher, J. F., Y. Leforban, M. Rweyemamu, P. L. Roeder, G. Gerbier, D. K. Mackay, K. J. Sumption, D. J. Paton, and N. J. Knowles. 2008. Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transbound. Emerg. Dis. 55:14-34.